Norinchukin Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2M | Buy |
9,240
+20
| +0.2% | +$3.83K | 0.02% | 336 |
|
|
2026
Q1 | $1.69M | Buy |
9,220
+34
| +0.4% | +$6.26K | 0.02% | 349 |
|
|
2025
Q4 | $1.62M | Sell |
9,186
-3,442
| -27% | -$562K | 0.02% | 351 |
|
|
2025
Q3 | $1.77M | Buy |
12,628
+143
| +1% | +$19.3K | 0.02% | 324 |
|
|
2025
Q2 | $1.57M | Buy |
12,485
+911
| +8% | +$114K | 0.02% | 327 |
|
|
2025
Q1 | $1.58M | Buy |
11,574
+3,542
| +44% | +$506K | 0.03% | 310 |
|
|
2024
Q4 | $1.23M | Buy |
8,032
+711
| +10% | +$120K | 0.03% | 327 |
|
|
2024
Q3 | $1.42M | Buy |
7,321
+1,023
| +16% | +$214K | 0.03% | 291 |
|
|
2024
Q2 | $1.46M | Buy |
6,298
+42
| +0.7% | +$9.13K | 0.04% | 241 |
|
|
2024
Q1 | $1.35M | Sell |
6,256
-125
| -2% | -$29.3K | 0.04% | 259 |
|
|
2023
Q4 | $1.65M | Sell |
6,381
-924
| -13% | -$227K | 0.04% | 213 |
|
|
2023
Q3 | $1.88M | Sell |
7,305
-7,675
| -51% | -$2.05M | 0.04% | 196 |
|
|
2023
Q2 | $4.27M | Buy |
14,980
+3,467
| +30% | +$1.03M | 0.07% | 177 |
|
|
2023
Q1 | $3.2M | Buy |
11,513
+290
| +3% | +$80.2K | 0.06% | 177 |
|
|
2022
Q4 | $3.11M | Sell |
11,223
-2,712
| -19% | -$766K | 0.07% | 173 |
|
|
2022
Q3 | $3.72M | Buy |
13,935
+1,383
| +11% | +$294K | 0.08% | 163 |
|
|
2022
Q2 | $2.56M | Sell |
12,552
-2,693
| -18% | -$551K | 0.05% | 207 |
|
|
2022
Q1 | $3.21M | Buy |
15,245
+1,366
| +10% | +$297K | 0.04% | 237 |
|
|
2021
Q4 | $3.33M | Sell |
13,879
-1,048
| -7% | -$269K | 0.04% | 224 |
|
|
2021
Q3 | $4.22M | Buy |
14,927
+740
| +5% | +$243K | 0.06% | 170 |
|
|
2021
Q2 | $4.91M | Buy |
14,187
+26
| +0.2% | +$7.88K | 0.07% | 144 |
|
|
2021
Q1 | $3.96M | Buy |
14,161
+525
| +4% | +$142K | 0.05% | 158 |
|
|
2020
Q4 | $3.34M | Sell |
13,636
-453
| -3% | -$117K | 0.05% | 167 |
|
|
2020
Q3 | $4M | Sell |
14,089
-6
| -0% | -$1.67K | 0.06% | 143 |
|
|
2020
Q2 | $3.77M | Sell |
14,095
-1,614
| -10% | -$485K | 0.06% | 139 |
|
|
2020
Q1 | $4.97M | Sell |
15,709
-14,015
| -47% | -$4.25M | 0.1% | 108 |
|
|
2019
Q4 | $8.82M | Sell |
29,724
-2,848
| -9% | -$790K | 0.12% | 117 |
|
|
2019
Q3 | $7.58M | Sell |
32,572
-947
| -3% | -$221K | 0.11% | 128 |
|
|
2019
Q2 | $7.84M | Sell |
33,519
-14,353
| -30% | -$3.31M | 0.12% | 114 |
|
|
2019
Q1 | $11.3M | Buy |
47,872
+219
| +0.5% | +$69K | 0.14% | 116 |
|
|
2018
Q4 | $14.3M | Buy |
47,653
+11,578
| +32% | +$3.69M | 0.2% | 95 |
|
|
2018
Q3 | $12.7M | Buy |
36,075
+1,487
| +4% | +$512K | 0.17% | 97 |
|
|
2018
Q2 | $10M | Buy |
34,588
+1,351
| +4% | +$380K | 0.15% | 98 |
|
|
2018
Q1 | $9.1M | Buy |
33,237
+5,614
| +20% | +$1.74M | 0.15% | 97 |
|
|
2017
Q4 | $8.8M | Buy |
27,623
+1,153
| +4% | +$370K | 0.15% | 94 |
|
|
2017
Q3 | $8.29M | Buy |
26,470
+656
| +3% | +$194K | 0.16% | 95 |
|
|
2017
Q2 | $7M | Buy |
25,814
+725
| +3% | +$192K | 0.14% | 96 |
|
|
2017
Q1 | $6.86M | Buy |
25,089
+845
| +3% | +$239K | 0.15% | 94 |
|
|
2016
Q4 | $6.88M | Buy |
24,244
+1,453
| +6% | +$431K | 0.16% | 91 |
|
|
2016
Q3 | $7.13M | Sell |
22,791
-5,170
| -18% | -$1.53M | 0.17% | 83 |
|
|
2016
Q2 | $6.76M | Buy |
27,961
+5,720
| +26% | +$1.51M | 0.16% | 86 |
|
|
2016
Q1 | $5.79M | Buy |
22,241
+571
| +3% | +$151K | 0.14% | 96 |
|
|
2015
Q4 | $6.64M | Sell |
21,670
-3,591
| -14% | -$1.03M | 0.17% | 84 |
|
|
2015
Q3 | $7.37M | Buy |
25,261
+145
| +0.6% | +$47.9K | 0.19% | 78 |
|
|
2015
Q2 | $10.1M | Sell |
25,116
-513
| -2% | -$206K | 0.26% | 57 |
|
|
2015
Q1 | $10.8M | Sell |
25,629
-381
| -1% | -$150K | 0.26% | 55 |
|
|
2014
Q4 | $8.83M | Buy |
26,010
+4,504
| +21% | +$1.46M | 0.22% | 60 |
|
|
2014
Q3 | $7.11M | Buy |
21,506
+575
| +3% | +$190K | 0.2% | 59 |
|
|
2014
Q2 | $6.6M | Sell |
20,931
-2,449
| -10% | -$737K | 0.19% | 57 |
|
|
2014
Q1 | $7.15M | Buy |
23,380
+14,557
| +165% | +$4.62M | 0.2% | 60 |
|
|
2013
Q4 | $2.47M | Sell |
8,823
-104
| -1% | -$26.9K | 0.07% | 106 |
|
|
2013
Q3 | $2.15M | Buy |
8,927
+706
| +9% | +$158K | 0.06% | 108 |
|
|
2013
Q2 | $1.77M | Buy |
+8,221
| New | +$1.76M | 0.05% | 115 |
|
Other funds holding BIIB
Norinchukin Bank's BIIB Position: Q2 2026 in Review
Norinchukin Bank increased its Biogen (BIIB) stake by 0.22% in Q2 2026, buying an estimated $3.83K and bringing the position to 9,240 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #336.
Norinchukin Bank first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q4 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Norinchukin Bank held 9,240 shares of Biogen worth $2M as of Q2 2026.
- Norinchukin Bank bought 20 Biogen shares in Q2 2026, an estimated $3.83K.
- Biogen made up 0.02% of Norinchukin Bank's portfolio in Q2 2026, its #336 holding.
- Norinchukin Bank first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Norinchukin Bank's Biogen position peaked at $14.3M in Q4 2018.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.